Opioid use and OUD treatment during COVID-19 and beyond

Noon - 1 p.m.

This event is open to HANYS members and non-members.

This session will address current epidemiology, new legislation and innovative resources in supporting persons with opioid use disorder. Clinical responses and current trends in substance use and overdoses will be explored and various buprenorphine resources will be discussed in the context of COVID-19. The webinar also will highlight New York MATTERS updates.

Learning objectives:

• review new resources being developed to address opioid use/OUD;
• identify current trends in substance use and overdoses;
• describe buprenorphine resources and other low threshold resources in the context of COVID-19;
• review New York MATTERS updates; and
• present current epidemiological statistics and briefly discuss new legislation.

Speakers:

Kelly S. Ramsey, MD, MPH, MA, FACP, FASAM, Chief of Medical Services, Office of Addiction Services and Supports

Sharon Stancliff, MD, Associate Medical Director of Harm Reduction in Healthcare, New York State Department of Health Aids Institute

This webinar is part of HANYS’ Commitment to Excellence Emerging Quality Trends Series. Each session will cover a different cutting-edge topic to expand healthcare providers' clinical expertise and share proven best practices to deliver high-quality care. For more information about this program, contact Erin Gretzinger, CPHQ, director, Quality Advocacy, Research, and Innovation, at 518.431.7744 or egretzin@hanys.org.

If you have questions regarding registration, please contact Registration Support at learning@hanys.org or 518.431.7867.